Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 2009
Business Overview: The Company manufactures and sells laboratory furniture and equipment. It operates through Domestic and International segments.
Key Financial Metrics
| Metric | Q1 FY2010 (Ended July 31, 2009) | Q1 FY2009 (Ended July 31, 2008) |
|---|---|---|
| Net Sales | $26,249,000 | $25,395,000 |
| Gross Profit | $5,764,000 | $5,351,000 |
| Gross Margin | 22.0% | 21.1% |
| Operating Earnings | $1,798,000 | $1,765,000 |
| Net Earnings (Attributable to Kewaunee) | $1,071,000 | $981,000 |
| Diluted EPS | $0.42 | $0.38 |
| Operating Cash Flow | $1,246,000 | ($726,000) |
| Cash and Equivalents (End of Period) | $3,044,000 | $3,131,000 |
| Short-Term Borrowings | $6,229,000 | $5,720,000 |
| Working Capital | $18,803,000 | $18,882,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3% year-over-year. Domestic Operations revenue rose 11% to $23.4 million, while International Operations revenue declined 34% to $2.9 million.
- Margin Expansion: Gross profit margin improved to 22.0% from 21.1%, driven by manufacturing efficiencies and cost savings on raw materials.
- Expense Increase: Operating expenses increased to $3.97 million (15.1% of sales) from $3.59 million (14.1% of sales). The primary driver was a $215,000 increase in pension expense.
- Cash Flow Improvement: Operating cash flow turned positive at $1.25 million, compared to a usage of $0.73 million in the prior year. This was largely due to a $616,000 decrease in accounts receivable.
- Inventory Build: Inventories increased by $1.51 million, consuming cash during the period.
Outlook, Risks, and Management Commentary
- Outlook: Management expects the second quarter of fiscal year 2010 to be profitable, though predicting future demand remains difficult due to general economic factors and the Company's role as a subcontractor/supplier.
- Order Backlog: The order backlog decreased slightly to $60.7 million at July 31, 2009, from $62.7 million at April 30, 2009.
- Debt Management: In July 2009, the Company amended its revolving credit facility, extending the expiration to July 31, 2012. It also entered an interest rate swap to fix the rate on $2 million of advances at 3.9% to mitigate interest rate risk.
- Risks: Forward-looking statements are subject to risks including economic conditions, competitive factors, and raw material prices. Demand is dependent on laboratory construction projects.
Investor Verification Checklist
- Verify the sustainability of the 11% revenue growth in Domestic Operations versus the 34% decline in International Operations.
- Monitor the impact of the $1.5 million inventory increase on future working capital requirements.
- Review the details of the amended credit facility and the fixed-rate swap agreement for future interest expense implications.
- Assess the stability of the order backlog ($60.7 million) relative to the current sales run rate.
- Confirm the trajectory of pension expenses, which significantly impacted operating margins this quarter.